Unknown residue CXM: ATOM 1 N CXM 1 53.953 64.825 81.936 1.00 32.19 N Unknown residue CXM: ATOM 2 CA CXM 1 54.411 65.910 82.638 1.00 32.65 C Unknown residue CXM: ATOM 3 CB CXM 1 53.255 66.726 83.291 1.00 33.63 C Unknown residue CXM: ATOM 4 CG CXM 1 52.307 67.320 82.269 1.00 34.13 C Unknown residue CXM: ATOM 5 SD CXM 1 50.960 68.320 82.971 1.00 32.47 S Unknown residue CXM: ATOM 6 CE CXM 1 49.817 66.950 83.287 1.00 32.66 C Unknown residue CXM: ATOM 7 C CXM 1 55.189 65.383 83.855 1.00 32.12 C Unknown residue CXM: ATOM 8 O CXM 1 54.803 64.308 84.370 1.00 31.47 O Unknown residue CXM: ATOM 9 CN CXM 1 54.189 65.026 80.609 1.00 32.57 C Unknown residue CXM: ATOM 10 ON1 CXM 1 53.498 64.174 80.062 1.00 32.53 O Unknown residue CXM: ATOM 11 ON2 CXM 1 54.022 66.062 79.953 1.00 31.77 O Unresolved disorder model. using A ATOM 26 CG AGLN 3 54.039 67.518 89.446 0.50 34.55 C Unresolved disorder model. using A ATOM 27 CG BGLN 3 53.585 67.806 89.012 0.50 33.84 C Unresolved disorder model. using A ATOM 28 CD AGLN 3 53.102 68.489 90.136 0.50 34.77 C Unresolved disorder model. using A ATOM 29 CD BGLN 3 53.655 68.685 87.797 0.50 33.79 C Unresolved disorder model. using A ATOM 30 OE1AGLN 3 52.915 68.365 91.349 0.50 33.29 O Unresolved disorder model. using A ATOM 31 OE1BGLN 3 54.276 68.331 86.782 0.50 34.13 O Unresolved disorder model. using A ATOM 32 NE2AGLN 3 52.536 69.398 89.360 0.50 35.70 N Unresolved disorder model. using A ATOM 33 NE2BGLN 3 53.055 69.879 87.813 0.50 33.36 N Unresolved disorder model. using A ATOM 603 CG AHIS 73 25.434 60.077 70.666 0.50 40.48 C Unresolved disorder model. using A ATOM 604 CG BHIS 73 24.849 60.366 68.881 0.50 41.16 C Unresolved disorder model. using A ATOM 605 ND1AHIS 73 24.755 58.903 70.885 0.50 41.65 N Unresolved disorder model. using A ATOM 606 ND1BHIS 73 23.846 60.079 67.992 0.50 41.93 N Unresolved disorder model. using A ATOM 607 CD2AHIS 73 26.722 59.862 71.061 0.50 40.86 C Unresolved disorder model. using A ATOM 608 CD2BHIS 73 25.892 59.649 68.467 0.50 43.30 C Unresolved disorder model. using A ATOM 609 CE1AHIS 73 25.599 58.027 71.407 0.50 42.18 C Unresolved disorder model. using A ATOM 610 CE1BHIS 73 24.289 59.221 67.116 0.50 43.19 C Unresolved disorder model. using A ATOM 611 NE2AHIS 73 26.791 58.586 71.522 0.50 41.16 N Unresolved disorder model. using A ATOM 612 NE2BHIS 73 25.543 58.936 67.356 0.50 42.47 N Unresolved disorder model. using A ATOM 1220 CG APHE 149 33.708 68.075 97.113 0.50 27.87 C Unresolved disorder model. using A ATOM 1221 CG BPHE 149 34.469 66.927 96.978 0.50 29.66 C Unresolved disorder model. using A ATOM 1222 CD1APHE 149 34.861 68.782 97.380 0.50 27.91 C Unresolved disorder model. using A ATOM 1223 CD1BPHE 149 34.445 65.700 97.625 0.50 30.94 C Unresolved disorder model. using A ATOM 1224 CD2APHE 149 32.669 68.194 98.027 0.50 26.53 C Unresolved disorder model. using A ATOM 1225 CD2BPHE 149 35.367 67.899 97.384 0.50 30.87 C Unresolved disorder model. using A ATOM 1226 CE1APHE 149 34.977 69.591 98.488 0.50 28.45 C Unresolved disorder model. using A ATOM 1227 CE1BPHE 149 35.329 65.431 98.649 0.50 30.88 C Unresolved disorder model. using A ATOM 1228 CE2APHE 149 32.764 69.000 99.150 0.50 27.29 C Unresolved disorder model. using A ATOM 1229 CE2BPHE 149 36.261 67.637 98.392 0.50 30.65 C Unresolved disorder model. using A ATOM 1230 CZ APHE 149 33.937 69.700 99.385 0.50 26.24 C Unresolved disorder model. using A ATOM 1231 CZ BPHE 149 36.226 66.401 99.001 0.50 31.42 C 1